The 30-minute film will incorporate a series of interviews, “live action” clips, (demonstrating training methodology), stills of our new website and App with narration throughout. We will show how our work has supported community engagement with science, the roll out of new antiretrovirals and the understanding of benefits and risks of ART in the community. Interviewees and participants will include: TAC treatment literacy trainers; AfroCAB members; key researchers on ART optimisation studies and colleagues from other partner organisations, such as WHO and CHAI, for which community engagement is also critical. Format as follows: Introduction – 2 minutes Film showing and explaining the different materials by treatment activists – 5 minutes Interview with researchers on ART optimisation studies – 5 minutes Interview with WHO representative – 5 minutes Interview with a partner organization in Zimbabwe – 5 minutes Film demonstrating training methodology by treatment activists in South Africa – 5 minutes Concluding remarks - 3 minutes

Biomedical prevention interventions have saved lives and helped prevent new HIV infections. However, declines in incidence remain far from UNAIDS targets. A safe and globally effective HIV vaccine remains a necessity for a durable control and end to the epidemic. Diverse and promising HIV vaccines candidates are in various stages of development and exciting results from vaccine efficacy and passive immunization trials are expected in the coming years. The vaccine field remains hopeful and determined - even with the necessary shift in attention to developing SARS-CoV-2 control measures. Communicating the wealth and breadth of ongoing research, and the steadfast commitments of funders, researchers, product developers and communities to find a vaccine remains critically important. Co-sponsored by the Enterprise, NIH/HVTN/HPTN, with the participation of the South African Medical Research Council, IAVI, EU consortiums and AVAC, this satellite will showcase current HIV vaccine research and development.

For nearly forty years, the National Institutes of Health (NIH) has conducted impactful, landmark HIV/AIDS research from innovative basic science discoveries through the pipeline to preclinical studies and novel clinical trials around the world. NIH-supported research is critical to reach ambitious but achievable goals to end the HIV epidemic in the United States by 2030 and HIV pandemic control globally. The satellite will highlight NIH HIV/AIDS research at the intersections of Prevention, Treatment and Disparities across the lifespan. Multidisciplinary scientists share unique insights, research findings, and experiences that will improve understanding of how the global and the domestic HIV epidemics can inform each other and accelerate epidemic control. The session aims to help build the capacity of current and future generations of HIV researchers and advocates to address 21st century challenges with 21st century solutions.

In February 2019, the U.S. Government (USG) launched Ending the HIV Epidemic: A Plan for America (EHE), an initiative working to lower the number of new HIV infections in the U.S. by 75% by 2025 and 90% by 2030. EHE prioritizes efforts in jurisdictions where most new infections occur and is founded on 4 pillars: Diagnose all individuals with HIV as early as possible after infection; Treat people with HIV rapidly and effectively to reach sustained viral suppression; Prevent new HIV transmissions by using proven interventions, including PrEP and SSPs; and Respond quickly to potential HIV outbreaks to get prevention and treatment services to people who need them. This session will feature a dialogue between USG leaders and community leaders charged with implementing EHE. The session will also include information on the USG's Ready, Set, PrEP program, a key component of EHE's Prevent pillar, which provides free PrEP medications to people who qualify.

The Robert Carr Fund is the world’s leading international fund focused on funding regional and global networks led by and involving and serving inadequately served populations (ISPs). As a cooperative effort of donors and civil society, the Robert Carr Fund is structured to maximize participation, empowerment, equity, transparency and accountability in our fundraising and grant making. The Robert Carr Fund works to mobilize and deliver core and strategic funding for regional and global networks to achieve four outcomes:

• Protecting and promoting human rights
• Improving access to HIV services
•Mobilizing and monitoring national and international funding for human rights and health
• Building capacity of civil society and community networks

Our goal: Improved health, inclusion and wellbeing for inadequately served populations (ISPs) This satellite event will celebrate and showcase the work and impact of civil society networks in the HIV response and will launch the recently agreed Robert Carr Fund strategy charting the fund’s course through to 2024. It will also focus on the COVID 19 crisis, the impact on communities and networks and the work of civil society networks in responding to the global pandemic.